The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: A retrospective analysis.
Aljaberi, N; Tronconi, E; Schulert, G; Grom, AA; Lovell, DJ; Huggins, JL; Henrickson, M; Brunner, HI.
Pediatric Rheumatology Online Journal.
2020;
18.
Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus.
Harry, O; Crosby, LE; Mara, C; Ting, TV; Huggins, JL; Modi, AC.
Pediatric Rheumatology Online Journal.
2020;
18.
Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.
Leong, JY; Chen, P; Yeo, JG; Ally, F; Chua, C; Hazirah, SN; Poh, SL; Pan, L; Lai, L; Lee, ES C; et al.
Annals of the Rheumatic Diseases.
2019;
78:1712-1721.
Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert, GS; Yasin, S; Carey, B; Chalk, C; Do, T; Schapiro, AH; Husami, A; Watts, A; Brunner, HI; Huggins, J; et al.
Arthritis and Rheumatology.
2019;
71:1943-1954.
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Brunner, HI; Holland, MJ; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Aydin, PO A; Wenderfer, SE; Levy, DM; et al.
Arthritis Care and Research.
2019;
71:579-590.
Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?.
Harry, O; Crosby, LE; Smith, AW; Favier, L; Aljaberi, N; Ting, TV; Huggins, JL; Modi, AC.
Lupus.
2019;
28:642-650.
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Hinze, CH; Foell, D; Johnson, AL; Spalding, SJ; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; et al.
Arthritis and Rheumatology.
2019;
71:451-459.
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.
Holland, MJ; Beresford, MW; Feldman, BM; Huggins, J; Norambuena, X; Silva, CA; Susic, G; Sztajnbok, F; Uziel, Y; Appenzeller, S; et al.
Arthritis Care and Research.
2018;
70:1621-1629.
Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus.
AlE'ed, A; Aydin, PO A; Al Mutairi, N; AlSaleem, A; Sonmez, HE; Henrickson, M; Huggins, JL; Ozen, S; Al-Mayouf, SM; Brunner, HI.
Lupus Science and Medicine.
2018;
5:e000275-e000275.
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Lovell, DJ; Johnson, AL; Huang, B; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; Taylor, J; et al.
Arthritis and Rheumatology.
2018;
70:1508-1518.